Amundi’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491M | Sell |
897,131
-706,770
| -44% | -$387M | 0.17% | 117 |
|
|
2025
Q1 | $980M | Buy |
1,603,901
+52,166
| +3% | +$31.9M | 0.36% | 55 |
|
|
2024
Q4 | $1.14B | Buy |
1,551,735
+487,489
| +46% | +$358M | 0.4% | 50 |
|
|
2024
Q3 | $1.07B | Sell |
1,064,246
-72
| -0% | -$72.4K | 0.39% | 53 |
|
|
2024
Q2 | $1.09B | Buy |
1,064,318
+7,859
| +0.7% | +$8.05M | 0.42% | 50 |
|
|
2024
Q1 | $945M | Buy |
1,056,459
+142,334
| +16% | +$127M | 0.41% | 50 |
|
|
2023
Q4 | $825M | Buy |
914,125
+228,839
| +33% | +$207M | 0.37% | 56 |
|
|
2023
Q3 | $575M | Buy |
685,286
+574
| +0.1% | +$482K | 0.28% | 81 |
|
|
2023
Q2 | $492M | Sell |
684,712
-87,503
| -11% | -$62.8M | 0.25% | 99 |
|
|
2023
Q1 | $637M | Buy |
772,215
+76,780
| +11% | +$63.4M | 0.34% | 62 |
|
|
2022
Q4 | $494M | Buy |
695,435
+40,245
| +6% | +$28.6M | 0.27% | 96 |
|
|
2022
Q3 | $489M | Buy |
655,190
+100,682
| +18% | +$75.1M | 0.29% | 83 |
|
|
2022
Q2 | $332M | Buy |
554,508
+55,578
| +11% | +$33.3M | 0.27% | 96 |
|
|
2022
Q1 | $360M | Buy |
498,930
+38,600
| +8% | +$27.9M | 0.24% | 105 |
|
|
2021
Q4 | $284M | Buy |
460,330
+33,873
| +8% | +$20.9M | 0.18% | 137 |
|
|
2021
Q3 | $258M | Buy |
426,457
+225,038
| +112% | +$136M | 0.18% | 137 |
|
|
2021
Q2 | $113M | Buy |
+201,419
| New | +$113M | 0.08% | 266 |
|